BVF Partners L P/il, 10% Owner at CTI BIOPHARMA CORP (CTIC), bought 1,001,327 shares at $1.22 ($1.2M) on 2016-01-07, disclosed to the SEC on 2016-01-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.22 | 8,091 | $10K | 0.8% |
| 2 | $1.22 | 29,655 | $36K | 3.0% |
| 3 | $1.22 | 87,747 | $107K | 8.8% |
| 4 | $1.22 | 508,287 | $619K | 50.8% |
| 5 | $1.22 | 32,571 | $40K | 3.3% |
| 6 | $1.22 | 58,613 |
| $71K |
| 5.9% |
| 7 | $1.22 | 90,049 | $110K | 9.0% |
| 8 | $1.22 | 186,314 | $227K | 18.6% |
| Total | $1.22 avg | 1,001,327 | $1.2M | 100% |
| Filing → |
| KYMR | BUY | 2022-05-31 | $8.3M | — | Filing → |
| IDYA | SELL | 2021-02-04 | $835K | — | Filing → |
| XOMA | BUY | 2020-03-27 | $284K | — | Filing → |